Europace

Europace 1999 1(3):174-178; doi:10.1053/eupc.1999.0034
© 1999 by European Society of Cardiology

This Article Abstract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (6) Request Permissions Disclaimer Google Scholar Articles by Capucci, A. Articles by De Seta, F. Search for Related Content PubMed PubMed Citation Articles by Capucci, A. Articles by De Seta, F. Social Bookmarking          What's this?

Dual chamber pacing with optimal AV delay in congestive heart failure

A randomized study

A. Capucci^*, S. Romano, A. Puglisi, M. Santini, M. Pagani^||, R. Cazzin^¶, D. Zanuttini^**, S. Mangiameli, P.V. Moracchini, R. Neri, P. De Ciuceis^||||, A. Circo^¶¶, S. Cavaglià^*** and F. De Seta^***

^*Civile Hospital Piacenza, Italy; Maggiore Hospital IRCCS Milano, Italy; Fatebenefratelli Hospital Isola Tiberina Roma, Italy; S. Filippo Neri Hosptial Roma, Italy; ^||Civile Hospital Legnano, Italy; ^¶Civile Hospital Portogruaro, Italy; ^**Civile Hospital Pordenone, Italy; Garibaldi Hospital Catania, Italy; S. Agostino Hospital Modena, Italy; G.B. Grassi Hospital Ostia, Italy; ^||||Silvestrini Hospital Perugia, Italy; ^¶¶S. Luigi Gonzaga Hospital Catania, Italy; ^***Medtronic Italia SpA Roma, Italy

AIM: A prospective randomized trial was set up to evaluate contractile parameters and quality of life in patients with congestive heart failure.

METHODS AND RESULTS: We describe the results from 38 patients in sinus rhythm and with chronic heart failure due to congestive cardiomyopathy, prospectively randomized to optimal medical therapy (Group 1, 19 patients) or optimal medical therapy plus dual chamber pacemaker programmed to optimal AV delay (Group 2, 19 patients).

At a 6 month follow-up, 7/19 patients in Group 1 had died compared with 5/19 patients in Group 2. During follow-up, there were few significant changes in evaluated parameters except for mitral regurgitation time, which was prolonged in Group 1 and shortened in Group 2. The systolic left ventricular diameter shortened significantly only in Group 2. An energy and activity questionnaire showed that the eVect of DDD pacing in the latter patient population was beneficial.

CONCLUSIONS: From these results we may conclude that at the 6 month follow-up DDD pacing with echo-optimized AV interval programming can improve quality of life without affecting survival.

Key Words: Congestive heart failure, dilated cardiomyopathy, dual chamber pacing

---

Correspondence: Dr A. Capucci, Ospedale Civile Cardiology Department, Via Taverna 49, 29100 Piacenza, Italy.

---

[1] Hochleitner M. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66: 198–202.[CrossRef][Web of Science][Medline]

[2] Brecker SJ. Effects of dual-chamber pacing with short atrio ventricular delay in dilated cardiomyopathy. Lancet 1992; 340: 1308–1312.[CrossRef][Web of Science][Medline]

[3] Auricchio A. Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. PACE 1993; 16: 2034–2042.

[4] Rector TS, Johnson G, Dunkman WB, et al. Enalapril versus Hydralazine plus Isosorbide Dinitrate. Supplement VI Circulation 1993; 87: VI71–VI77.

[5] Gold MR. Dual chamber pacing with short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995; 26: 967.[Abstract]

[6] Linde C. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995; 75: 919.[CrossRef][Web of Science][Medline]

[7] Cazeau S. Four chamber pacing in dilated cardiomyopathy. PACE 1994; 17: 1974–1979.

[8] Brecker SJ. What is the role of pacing in dilated cardiomyopathy? Eur Heart J 1996; 17: 819–824.[Free Full Text]

[9] Smith LE, Fabbri SA, Pai R, Ferry D, Heywood JT. Symptomatic improvement and reduced hospitalization for patients attending a cardiomyopathy clinic. Clin Cardiol 1997; 20: 949–954.[Web of Science][Medline]

[10] Stevenson LW. Afterload reduction with vasodilators and diuretics decreases mitral valve regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol 1990; 15: 174–180.[Abstract]

[11] Stevenson LW. Effects of afterload reduction on left ventricular volume and mitral regurgitation in severe heart failure. Am J Cardiol 1987; 60: 654–658.[CrossRef][Web of Science][Medline]

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				T. V. Salukhe, D. Dob, and R. Sutton Pacemakers and defibrillators: anaesthetic implications Br. J. Anaesth., July 1, 2004; 93(1): 95 - 104. [Abstract] [Full Text] [PDF]

				T. V. Salukhe, M. Y. Henein, and R. Sutton Pacing in heart failure: patient and pacing mode selection Eur. Heart J., June 1, 2003; 24(11): 977 - 986. [Full Text] [PDF]

This Article Abstract FREE Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (6) Request Permissions Disclaimer Google Scholar Articles by Capucci, A. Articles by De Seta, F. Search for Related Content PubMed PubMed Citation Articles by Capucci, A. Articles by De Seta, F. Social Bookmarking          What's this?